Impact of the COVID-19 pandemic on continuity of medical treatment for patients with chronic diseases in Japan: a retrospective cohort analysis
The COVID-19 pandemic was associated with an increased risk of treatment interruption in patients with chronic diseases, underscoring the need for targeted strategies to maintain care continuity during public health emergencies. While older patients and those with multimorbidity showed earlier interruptions, the overall patterns persisted across disease groups, emphasizing the importance of preemptive measures and patient outreach to prevent delayed or forgone care.
Authors
- Naohiro Mitsutake (ORCID: https://orcid.org/0000-0003-1809-5426)
- Kazuo Goda (ORCID: https://orcid.org/0000-0003-0618-4157)
- Hiromasa Yoshimoto (ORCID: https://orcid.org/0000-0001-9702-2879)
- Yoshimitsu Takahashi (ORCID: https://orcid.org/0000-0003-4073-9945)
- Tomoki Ishikawa (ORCID: https://orcid.org/0000-0001-8725-6508)
- Takeo Nakayama (ORCID: https://orcid.org/0000-0002-7918-6252)
- Masaru Kitsuregawa (ORCID: https://orcid.org/0000-0003-4027-2994)
- Jumpei Sato (ORCID: https://orcid.org/0000-0001-6032-1584)
- Akihito Kako
- Junko Hattori (ORCID: https://orcid.org/0000-0001-7452-0306)
Institutions
- Kyoto University (JP)
- Institute for Health Economics and Policy (JP)
- The University of Tokyo (JP)
Publication Details
- Journal
- BMC Health Services Research
- Published
- 2025-05-19
- DOI
- https://doi.org/10.1186/s12913-025-12798-3
- Citations
- 3
- Primary Topic
- Chronic Disease Management Strategies
- Type
- article
- Field-Weighted Citation Impact
- 4.06
Funders
- Japan Agency for Medical Research and Development